Gilead: Avoid 2017`s Frustrations
(WorldNews Health)

How did 2017 as a Gilead (GILD) investor / trader go for you? Considering the stock opened the year at $72.34, and currently sits at $74.22 it shouldn`t have been too bad. Frustrating perhaps, with so much promise, and other stocks performing so well, but there were much worse stocks to be holding. One of the big frustrations was the rally from the June lows running out of steam around $86 and giving the majority of the gains back. Many hoped for more. But I wonder why. Temper Your Expectations GILD fell for most of 2016 and the first half of 2017 for reasons clear to see. HCV sales were falling drastically. Yet GILD was never going to go the way of other Biotechs and crash. It was paying a...